RHOA and ovarian cancer: The rs927062 variant of ARHGAP5 was found to be associated with increased endometrioid and invasive serious ovarian cancer risk [125] and a statistically significant decrease of ARHGAP5 protein which would be predicted to increase Rac1 and RhoA activity.